A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LAV / lymphadenopathy-associated virus

[Related PubMed/MEDLINE]
Total Number of Papers: 66
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LAV  (>> Co-occurring Abbreviation)
Long Form:   lymphadenopathy-associated virus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1989 Acquired immunodeficiency syndrome. HIV
1988 Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus. HIV, NK
1987 A second discriminator for biological false positive results in enzyme-linked immunosorbent assays for antibodies to human immunodeficiency virus (HTLV-III/LAV). BFP, ELISA, HTLV-III
1987 Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV). AIDS, ARV, HIV, HTLV-III B
1987 Molecular evolution and phylogeny of the human AIDS viruses LAV, HTLV-III, and ARV. AIDS, ARV, HTLV-III
1987 Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. ADCC, AIDS, HTLV
1986 A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. mAb
1986 Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. gp110, HTLV-III
1986 Budding process and fine structure of lymphadenopathy-associated virus (LAV). EM, IF
10  1986 Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. AIDS, ARV, CNS, HTLV-III
11  1986 Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). ---
12  1986 Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations. AIDS, ARC, EIA, HTLV-III, ITP
13  1986 Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. AIDS, FeLVs, HTLV-III, SPF, UVD
14  1986 Elimination of infectious retroviruses during preparation of immunoglobulins. AIDS
15  1986 Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III). HTLV-III
16  1986 Expression of AIDS virus envelope gene in recombinant vaccinia viruses. AIDS, ARV, Env, HTLV-III
17  1986 Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. AIDS, Env, gp120, HTLV-III, Mr, SV40
18  1986 Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. AIDS, HTLV-III, PGL, STDs
19  1986 Genomic variability of selected LAV-related AIDS retroviruses. ---
20  1986 High production of the acquired immunodeficiency syndrome virus (lymphadenopathy-associated virus) by human T lymphocytes stimulated by streptococcal mitogenic toxins. PHA, SMs
21  1986 HIV infection: facts and hypotheses. AIDS, HIV
22  1986 Induction of anti-HIV neutralizing antibodies by synthetic peptides. AIDS, HIV, HTLV
23  1986 Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. HTLV-III
24  1986 Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III. EIAs, HTLV-III
25  1986 Narrow host range of AIDS-related retroviruses (YU-1, 2, 3, 4) isolated from Japanese hemophiliacs: inability to infect H9, Molt-4, and MT-4 cells. ARV, HTLV-III
26  1986 Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. IgG
27  1986 Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. AIDS, HTLV-III
28  1986 Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine. AIDS, AZT, HTLV-I, MoMLV, RLV
29  1986 T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses. AIDS, ARV, HIV, HTLV-III, IL-2
30  1986 Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia. HTLV-III
31  1986 Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. AIDS, HTLV-III
32  1986 Tumor promoter, TPA, enhances replication of HTLV-III/LAV. HTLV-III, TPA
33  1986 Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus. AIDS, FITC, PE
34  1986 [LAV infections and the acquired immunodeficiency syndrome in infants]. ---
35  1986 [Molecular biology of human T-lymphotropic retroviruses (HTLV)]. AIDS, HTLV, HTLV-I
36  1985 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. AIDS, HTLV-III
37  1985 Acquisition of antibody to lymphadenopathy-associated virus in patients with classic hemophilia (factor VIII deficiency). ---
38  1985 An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS. AIDS, HTLV-III, Mr
39  1985 Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. AIDS
40  1985 Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). ELISA
41  1985 Immunologic and virologic status of multitransfused patients: role of type and origin of blood products. By the AIDS-Hemophilia French Study Group. ---
42  1985 Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. AIDS
43  1985 Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate. ---
44  1985 Lymphadenopathy-associated virus: from molecular biology to pathogenicity. ---
45  1985 Nucleotide sequence of the AIDS virus, LAV. ---
46  1985 Radioimmunoassay and enzyme-linked immunoassay of antibodies directed against lymphadenopathy-associated virus (LAV) proteins larger than the core protein (P24). AIDS, anti-PL, ELISA, PL, RIA
47  1985 Safety of human blood products: inactivation of retroviruses by heat treatment at 60 degrees C. AIDS
48  1985 Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan. AIDS, ATLV or HTLV-I
49  1985 Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. HTLV-III
50  1984 Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. ---
51  1984 Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. AIDS
52  1984 Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). TdT
53  1984 Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. ---
54  1984 Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. AIDS
55  1984 Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. HTLV
56  1984 Lymphadenopathy associated virus and its etiological role in AIDS. AIDS, Env, HTLV
57  1984 Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. AIDS
58  1984 Molecular cloning of AIDS-associated retrovirus. AIDS, kb
59  1984 Molecular cloning of lymphadenopathy-associated virus. AIDS, ARV, HTLV-III
60  1984 Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. AIDS
61  1984 Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. ---
62  1984 Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. AIDS
63  1984 Structural and epidemiological features of primate lymphotropic retroviruses. AIDS, ATLV, HTLV-I, PLRV, PLRVs
64  1984 T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. AIDS, EBV, HLA, TNK
65  1984 [Viral etiologies of AIDS: facts and hypotheses]. AIDS, HTLV, SAIDS
66  1983 Establishment of retrovirus-, Epstein-Barr virus-positive B-lymphoblastoid cell lines derived from individuals at risk for acquired immune deficiency syndrome (AIDS). AIDS, EBV, HTLV-III, RT